Skip to main content
. 2012 Jul 19;7:71. doi: 10.1186/1749-8090-7-71

Table 1.

Baseline Patient Characteristics (n = 19)

Age 61.2 ± 8.6
M/F
16/3 (84.2/15.8)
BMI
27.6 ± 4.6
Hypertension
7 (36.8)
TIA/CVA
1 (5.2)
Preoperative catheter ablation
 
AF
4 (21.1)
Flutter
5 (26.3)
Type of preoperative AF
 
Paroxysmal
5 (26.3)
Persistent
4 (21.1)
Long-standing persistent
10 (52.6)
Prevalence of AF (68% CI)
 
Paroxysmal
20.0 (16.8–23.3)
Persistent
34.7 (31.2–38.9)
Long-standing persistent
63.6 (59.9–67.1)
EHRA Score
4 [3–4]
Duration of preoperative AF (yrs.)
5 [3–8.5]
Antyarrhythmic Drugs
 
Amiodaron
2 (10.5)
Dysopiramide
1 (5.3)
Flecainide
6 (31.5)
Propaphenon
1 (5.3)
Sotalol
5 (26.3)
Electrical cardioversion
15 (78.9)
Previous Catheter Ablation
 
For AF
6 (31.5)
For Atrial Flutter
5 (26.3)
Preoperative Pacemaker
2 (10.5)
Anticoagulant status
 
Sodium Warfarin
16 (84.2)
Aspirin
5 (26.3)
LAVI (mL/m2)
47 ± 11
LAMAX (mL/m2)
49 ± 20
LAMIN (mL/m2)
30 ± 15
LAEF (%)
38 ± 12
LA A-P (cm)
5.0 ± 0.5
LA S-I (cm) 6.4 ± 0.5

Normal data were presented as mean ±1 Standard deviation (SD), non parametric data as Median and [Interquartile Range] and discrete data as percentage (%).

Abbreviations: M/F: Male/Female; BMI: Body mass index; AF: Atrial fibrillation; CI: Confidence Interval; EHRA: European Hear Rhythm Association; LAVI: (Biplane) Left Atrial Volume Index; LAMAX: Maximum Left Atrial Volume; LAMIN: Minimum Left Atrial Volume; LAEF: Left Atrial emptying Fraction; LA A-P: Left Atrial Antero-Posterior Diameter; LA S-I : Left Atrial Superior-Inferior diameter.